Seven new medicines, including GW Pharma's orphan cannabidiol product, Epidyolex, are due for an opinion from the European Medicines Agency this week on whether they should be recommended for pan-EU approval.

Bracco Imaging is paying $450m to buy Blue Earth Diagnostics from London-listed venture capital firm Syncona Investment Management Ltd.

The latest drug development news and highlights from our US FDA Performance Tracker.

Biopharma financing finished off 2017 strong with a total value of $14.5 billion in Q4, led again by FOPOs. CVS' massive $77 billion acquisition of Aetna resulted in an all-time quarterly high in the M&A category, and the largest alliances were dominated by the development of vaccines and antibodies.